Please use this identifier to cite or link to this item:
|Title:||Altered apolipoprotein e glycosylation is associated with Aβ(42) accumulation in an animal model of Niemann-Pick Type C disease|
Niemman-Pick Type C
|Citation:||Chua, C.-C., Lim, M.-L., Wong, B.-S. (2010-03). Altered apolipoprotein e glycosylation is associated with Aβ(42) accumulation in an animal model of Niemann-Pick Type C disease. Journal of Neurochemistry 112 (6) : 1619-1626. ScholarBank@NUS Repository. https://doi.org/10.1111/j.1471-4159.2010.06586.x|
|Abstract:||Neurodegeneration is the final cause of death in Niemann-Pick Type C (NPC) disease, a cholesterol-storage disorder. Accumulating evidence indicates that NPC may share common pathological mechanisms with Alzheimer's disease, including the link between aberrant cholesterol metabolism and amyloid-β (Aβ) deposition. Apolipoprotein E (apoE) is highly expressed in the brain and plays a pivotal role in cholesterol metabolism. ApoE can also modulate Aβ production and clearance, and it is a major genetic risk factor for Alzheimer's disease. Although apoE is glycosylated, the functional significance of this chemical alteration on Aβ catabolism is unclear. In this study using an NPC animal model, we detect specific changes in apoE glycosylation that correlate with increased Aβ(42) accumulation prior to the appearance of neurological abnormalities. This suggests that increased apoE expression could be a compensatory response to the increased Aβ(42) deposition in NPC nih mice. We also observe what appears to be a simplification of the glycosylation process on apoE during neurodegeneration. © 2010 International Society for Neurochemistry.|
|Source Title:||Journal of Neurochemistry|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Dec 12, 2018
WEB OF SCIENCETM
checked on Nov 27, 2018
checked on Nov 23, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.